NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related

IA2 and Splaine Consulting have created policy report for American Indian and Alaska Native Alzheimer's Disease and Related Dementia Issues

Alzheimer's Disease Fact Sheet Publication Ordering System and Contact Report System

Final FY2023 Omnibus Bill Includes Advance Appropriations for the Indian Health Service and Several Other Priorities - NCUIH

Exploring the Multitarget Activity of Wedelolactone against Alzheimer's Disease: Insights from In Silico Study

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 - The Lancet Neurology

Alzheimer's report hints at a future health crisis bigger than COVID-19 – Orange County Register

Tribal Law and Policy: Alzheimer's Disease and Related Dementia Issues - International Association for Indigenous Aging

Public Health Reports in 2022: Impact Factor Increase; COVID-19 Coverage; Authorship by State, Tribal, Local, and Territorial Agencies; and New Department on Public Health Ethics - Andrey Kuzmichev, Noelle M. Harada, Christine

With More Than 250,000 Alzheimer's Patients, VA Is a Market for New Drug - U.S. Medicine

Examining the National Representativeness of the Axon Registry

Advancing New Research on Alzheimer's and Brain Health

Genetic and environmental factors in Alzheimer's and Parkinson's diseases and promising therapeutic intervention via fecal microbiota transplantation

AC Immune reports positive data from Alzheimer's disease vaccine

Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019

Lecanemab: How Effective is New Alzheimer's Drug Leqembi? - GoodRx

Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach